Global Blood Screening Market According to Data Bridge Market Research new Market report,
• “By Technology (Nucleic Acid Amplification, Reverse Polymerase Chain Reaction, Rapid Test, NGS , Western Blotting, ELISA),
• By Product (Instrument, Reagent, Kits, Software),
• By End-User (Blood Bank, Hospitals),
• By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 4.53 billion by 2025, at a CAGR of 9.9% during the forecast period of 2018 to 2025.
Global Blood Screening Market
 Over 20million of the peoples is estimated to be affected by HTLV-1. And over 90.0% of the affected people remain asymptomatic throughout their life. The most important route for transmission of this virus is from mother to child, form breastfeeding, through sexual intercourse, blood contact. There are 20.0% of chances that this virus can be transferred through mother to child.
 It was found that japan is the most endemic area where HTLV-1 is present. There are three tests to diagnose HTLV. They are ELISA, Confirmatory blot, PCR (polymerase chain reaction). According to CNN human T-cell leukemia virus type 1 or HTLV-1 infects 40.0% of adults in some parts of Australia with indigenous communities around the town of Alice Springs.
 According to the article by national institute of health there are around 5-10million individual infected by HTLV-1. The highly endemic regions are southwestern part of Japan; sub Saharan Africa, South America, and the Caribbean area. The diagnosis test for this virus is enzyme-linked immunoassay (EIA) or particle agglutination (PA) assays. EIA can be used to test HTLV1 as well as HTLV2 but Particle agglutination (PA) is used for detection of only HTLV1.
Segmentation: Global Blood Screening Market
The global market for blood screening by the following sub-categories is presented
By Technology
• Nucleic Acid Amplification
• Reverse Polymerase Chain Reaction
• Rapid Test
• NGS
• Western blotting
• ELISA
• CLIA
• Fluorescence assay
By Product Type
• Instrument
• Reagent
• Kits
• Software
By End-User
• Blood bank
• Hospitals
By Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa
FACTORS DRIVING GROWTH IN GLOBAL BLOOD SCREENING MARKET
Increase in blood donation:
 According to the report presented by WHO, it states that around 112.5 million blood donation are collected globally. Approximately half of this is collected from high income countries, which is the home for 19.0% of the total world’s population.
 In low income countries around 65.0% of blood is transfuse to the children below 5 years of age. And in high income countries around 76.0% of total transfusion is done for the persons whose age is above 65years. Based on the samples for 1000 people, blood donation rate is 32.1% from high income country, 14.9% from upper middle income countries, 7.8% donation from lower middle income country, and 4.6% blood donation from lower income country. It was seen that there was about 10.7 million increased in blood donations from unpaid donors has been reported from 2008-2013. 74 countries collect 90.0% of blood donation from unpaid volunteers.
 According to WHO, the blood screening is made compulsory for the detection of various diseases such as HIV, hepatitis B, hepatitis C, and syphilis.
 According to the New England journal of medicine, from June 2012-September 2014 around 89,153 blood donation samples were tested for B. microti antibodies or Babesia microti which is actually cause by the transfusion of blood. Around 335 that is 0.38% of the blood samples were confirmed to be positive.
Growing incidence of infectious disease:
 Human immunodeficiency virus is one of the most leading infectious diseases claiming for more than 25 million lives for the past 30 years. According to a study 2010 it was found that approximately 30 million of the people are living with HIV. As once someone is infected with HIV it is present in his body permanently.

Key players in the blood screening market include
• Grifols,
• Thermo Fisher Scientific Inc,
• F. Hoffmann-La Roche Ltd,
• bioMérieux SA,
• Bio-Rad Laboratories, Inc,
• Siemens Healthcare GmbH,
• Abbott.,
• Ortho Clinical Diagnostics, BD,
• Beckman Coulter, Inc.
• Sysmex Corporation,
• Koninklijke Philips N.V.,
• Quest Diagnostics Incorporated,
• PerkinElmer Inc,
• Luminex Corporation,
• Illumina, Inc,
• Hologic Inc,
• ARKRAY, Inc among others.
About Us:
Data bridge Market Research is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our client’s needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few
Contact Us:
Data Bridge Market Research
Toll Free: +1-888-387-2818
Email - [email protected]